Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04279483 · ClinicalTrials.gov registry record · NA
GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers' Exposure to Retail Environments
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 343
- Enrollment target
NCT04279483 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 343 participants.
The verdict
NCT04279483, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 343 participants
- Enrollment target
Study Summary
The purpose of the study is to learn more about the relationships between the brain, behavior, and natural daily exposure to particular environments, including the places where smokers regularly spend time and specific retail outlets.
Interventions
- BEHAVIORAL Tobacco retailer
- BEHAVIORAL Non-tobacco retailer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 343 participants |
| Start Date | 2019-12-17 |
| Est. Completion | 2024-06-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04279483
The ClinicalTrials.gov registry entry for NCT04279483 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 343 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tobacco retailer is the first listed.
NCT04279483 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04279483 about?
NCT04279483 is a clinical study titled "GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers' Exposure to Retail Environments". The purpose of the study is to learn more about the relationships between the brain, behavior, and natural daily exposure to particular environments, including the places where smokers regularly spend time and specific retail outlets.
What is the current status of trial NCT04279483?
This trial is currently completed. It is a NA study. The enrollment target is 343 participants. The study started on 2019-12-17. Estimated completion is 2024-06-10.
What interventions are being tested in trial NCT04279483?
The interventions under investigation include: Tobacco retailer (BEHAVIORAL), Non-tobacco retailer (BEHAVIORAL).
Who is sponsoring clinical trial NCT04279483?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.